» Articles » PMID: 34451446

The EBV-Encoded Oncoprotein, LMP1, Recruits and Transforms Fibroblasts Via an ERK-MAPK-Dependent Mechanism

Overview
Journal Pathogens
Date 2021 Aug 28
PMID 34451446
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Latent membrane protein 1 (LMP1), the major oncoprotein encoded by Epstein-Barr virus (EBV), is expressed at widely variable levels in undifferentiated nasopharyngeal carcinoma (NPC) biopsies, fueling intense debate in the field as to the importance of this oncogenic protein in disease pathogenesis. LMP1-positive NPCs are reportedly more aggressive, and in a similar vein, the presence of cancer-associated fibroblasts (CAFs) surrounding "nests" of tumour cells in NPC serve as indicators of poor prognosis. However, there is currently no evidence linking LMP1 expression and the presence of CAFs in NPC. In this study, we demonstrate the ability of LMP1 to recruit fibroblasts in vitro in an ERK-MAPK-dependent mechanism, along with enhanced viability, invasiveness and transformation to a myofibroblast-like phenotype. Taken together, these findings support a putative role for LMP1 in recruiting CAFs to the tumour microenvironment in NPC, ultimately contributing to metastatic disease.

Citing Articles

Deciphering the Role of Epstein-Barr Virus Latent Membrane Protein 1 in Immune Modulation: A Multifaced Signalling Perspective.

Simicic P, Batovic M, Stojanovic Markovic A, Zidovec-Lepej S Viruses. 2024; 16(4).

PMID: 38675906 PMC: 11054855. DOI: 10.3390/v16040564.


Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes.

Liu H, Tang L, Li Y, Xie W, Zhang L, Tang H Mol Cancer. 2024; 23(1):20.

PMID: 38254110 PMC: 10802008. DOI: 10.1186/s12943-023-01928-2.


Roles of the HIF-1α pathway in the development and progression of keloids.

Tai Y, Zheng L, Liao J, Wang Z, Zhang L Heliyon. 2023; 9(8):e18651.

PMID: 37636362 PMC: 10448433. DOI: 10.1016/j.heliyon.2023.e18651.


Effects of Exosomal Viral Components on the Tumor Microenvironment.

Li J, Zhang Y, Luo B Cancers (Basel). 2022; 14(14).

PMID: 35884611 PMC: 9317196. DOI: 10.3390/cancers14143552.


Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies.

Zheng X, Huang Y, Li K, Luo R, Cai M, Yun J Viruses. 2022; 14(5).

PMID: 35632758 PMC: 9146158. DOI: 10.3390/v14051017.

References
1.
Tao Q, Young L, Woodman C, Murray P . Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics. Front Biosci. 2006; 11:2672-713. DOI: 10.2741/2000. View

2.
Mueller M, Fusenig N . Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer. 2004; 4(11):839-49. DOI: 10.1038/nrc1477. View

3.
Morrison C, Parvani J, Schiemann W . The relevance of the TGF-β Paradox to EMT-MET programs. Cancer Lett. 2013; 341(1):30-40. PMC: 3752409. DOI: 10.1016/j.canlet.2013.02.048. View

4.
Miyazono K . Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proc Jpn Acad Ser B Phys Biol Sci. 2009; 85(8):314-23. PMC: 3621568. DOI: 10.2183/pjab.85.314. View

5.
Santiago J, Dangerfield A, Rattan S, Bathe K, Cunnington R, Raizman J . Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Dev Dyn. 2010; 239(6):1573-84. DOI: 10.1002/dvdy.22280. View